SCHEMBL12997229

SCHEMBL12997229

CCOC(CCNC(=O)c1ccc(N)cc1)OCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ MAPK1 P28482 2/20 0.55
▸ SLC22A2 O15244 1/20 0.55
▸ SLC22A1 O15245 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ ACHE P22303 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ BLM P54132 1/20 0.54
▸ PMP22 Q01453 1/20 0.54
▸ ESRRG P62508 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ SLC22A6 Q4U2R8 1/20 0.47
▸ SLC22A8 Q8TCC7 1/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ HDAC3 O15379 3/20 0.46
▸ HDAC4 P56524 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18023657 0.85 PLK1 (0.50) LMNAALDH1A1MAPK1MAPTNPC1
SCHEMBL12997232 0.84 HDAC3 (0.50) ALDH1A1MAPK1TSHRNPC1RAB9A
SCHEMBL29798859 0.83 NPC1 (0.58) ALDH1A1MAPK1TSHRNPC1RAB9A
SCHEMBL17978853 0.83 NPC1 (0.48) ALDH1A1MAPK1TSHRMAPTNPC1
SCHEMBL3705474 0.80 RAB9A (0.67) LMNAALDH1A1MAPK1SLC22A2SLC22A1
SCHEMBL18259815 0.78 NPC1 (0.52) ALDH1A1MAPK1TSHRNPC1RAB9A
SCHEMBL1290599 0.77 LMNA (0.68) LMNAALDH1A1MAPK1SLC22A2SLC22A1
SCHEMBL18259868 0.77 POLB (0.61) ALDH1A1MAPK1TSHRMAPTNPC1
SCHEMBL9344489 0.77 KDM4E (0.68) LMNAALDH1A1MAPK1SLC22A2SLC22A1
Hydrochloric Acid SCHEMBL5921713 0.76 LMNA (0.69) LMNAALDH1A1MAPK1SLC22A2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130230898-A1 HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-09-05 — — US disclosed
US-20130230898-A1 HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-09-05 — — US disclosed
US-8404834-B2 Hydroxyalkyl starch derivatives and process for their preparation FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-03-26 — — US disclosed
US-8404834-B2 Hydroxyalkyl starch derivatives and process for their preparation FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-03-26 — — US disclosed
EP-2231711-B1 HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DE GMBH (DE) 2012-11-07 — — EP disclosed
US-20100305033-A1 HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2010-12-02 — — US disclosed
US-20100305033-A1 HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2010-12-02 — — US disclosed
WO-2009077154-A1 HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2009-06-25 — — WO disclosed
EP-2070950-A1 Hydroxyalkyl starch derivatives and process for their preparation Fresenius Kabi Deutschland GmbH (DE) 2009-06-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305033-A1 HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION HDHD5, KHK, SORD LMNA 1787/4885ALDH1A1 1604/4885MAPK1 2597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback